Mercer Global Advisors
NXL icon

Mercer Global Advisors’s Nexalin Technology NXL Stock Holding History

Mercer Global Advisors’s Portfolio NXL Stock Details NXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330 Buy
+1,000
New +$411 ﹤0.01% 5871

Other funds holding NXL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
KA
Kovack Advisors Ft. Lauderdale, Florida $2.08B AUM 38.95% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SG
StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Mercer Global Advisors's NXL Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Nexalin Technology (NXL) in Q2 2026: 1,000 shares worth $330. The stake represents ﹤0.01% of the portfolio and ranks #5871 among its holdings.

12 funds tracked by Wall St. Rank hold NXL as of Q2 2026.

  • Mercer Global Advisors held 1,000 shares of Nexalin Technology worth $330 as of Q2 2026.
  • Nexalin Technology was a new Mercer Global Advisors position in Q2 2026.
  • Nexalin Technology made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5871 holding.
  • 12 funds tracked by Wall St. Rank held Nexalin Technology as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.